Name: 4Dmedical (4DX) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

4DX

Health Care Equipment & Services

4Dmedical

Short interest: 10.91%; −1.43 pp 30d; as of 9 Oct 2026
Reported shorts: 65.7M
Shares on issue: 602.031M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About 4Dmedical

4DMEDICAL LIMITED specializes in advanced medical imaging software and hardware tailored for respiratory medicine, using cutting-edge imaging technology to provide detailed insights into lung health. The company is a leader in transforming respiratory diagnostics with its innovative XV Technology, offering non-invasive imaging solutions that significantly improve diagnostic accuracy.

Company profile →

4Dmedical (ASX:4DX) has 10.91% of its shares on issue reported as short positions as of 9 Oct 2026, or about 65,695,510 shares. Over the past 30 days that figure has fallen 1.43 percentage points, and over 90 days it has fallen 1.17 percentage points. Its highest recorded short interest was 13.40% in July 2026. 4DX is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads 4DX today

Zanger BreakoutWatchScore 10rank 1686 of 1942
CAN SLIMWatchScore 16rank 808 of 1541
Minervini Trend TemplateWatchScore 32rank 498 of 1716
Crowded-Short BreakoutSetupScore 46rank 20 of 1500
Quality compoundersWatchScore 20rank 768 of 1669

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

4DX fundamentals

In the year to 30 Jun 2026, 4Dmedical (ASX:4DX) recorded revenue of A$7.1M and a net loss after tax of A$204.4M. A year earlier it recorded revenue of A$5.8M and a net loss after tax of A$30.1M. Year-on-year growth: revenue +22.2% (FY). Net margin −2,895.1% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →